ArticleEuropean journal of clinical pharmacology2024

Physiologically based pharmacokinetic modeling of apixaban to predict exposure in populations with hepatic and renal impairment and elderly populations.

Yichao Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.